| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.098 | 0.06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.09 | 0.07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.086 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.073 | 0.2 |